The Current Ratio as of December 2025 (TTM) for LENZ Therapeutics, Inc. (LENZ) is 20.54

According to LENZ Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 20.54. This represents a change of -11.29% compared to the average of 23.16 of the last 4 quarters.

LENZ Therapeutics, Inc. (LENZ) Historical Current Ratio (quarterly & annually)

How has LENZ Current Ratio performed in the past?

The mean historical Current Ratio of LENZ Therapeutics, Inc. over the last ten years is 18.80. The current 20.54 Current Ratio has changed 10.83% with respect to the historical average. Over the past ten years (40 quarters), LENZ's Current Ratio was at its highest in in the June 2021 quarter at 48.96. The Current Ratio was at its lowest in in the March 2020 quarter at 0.

LENZ Therapeutics, Inc. (LENZ) Current Ratio by Quarter and Year

Discovering the peaks and valleys of LENZ Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

LENZ Therapeutics, Inc. (LENZ) Average Current Ratio

How has LENZ Current Ratio performed in the past?

The current Current Ratio of LENZ Therapeutics, Inc. (LENZ) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

LENZ Therapeutics, Inc. (LENZ) Current Ratio vs. Peers

How is LENZ’s Current Ratio compared to its peers?

LENZ Therapeutics, Inc.’s Current Ratio is less than GH Research PLC (29.49), greater than ARS Pharmaceuticals, Inc. (6.66), greater than Nanobiotix S.A. (1.04), greater than Maravai LifeSciences Holdings, Inc. (5.29), greater than Rezolute, Inc. (15.15), greater than Geron Corporation (5.96), less than Tyra Biosciences, Inc. (21.94), greater than Savara Inc. (11.08), greater than Prime Medicine, Inc. (6.61), greater than Arbutus Biopharma Corporation (18.80),

Build a custom stock screener for LENZ Therapeutics, Inc. (LENZ) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like LENZ Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

LENZ Therapeutics, Inc. (LENZ) and other stocks custom spreadsheet templates

The easiest way to analyze a company like LENZ Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.